Logo

Cepheid Patents Nucleic Acid Prep System

Aug 29, 2002

NEW YORK, Aug. 29-Cepheid was granted a patent earlier this week for its automated cell capture, nucleic acid extraction, purification and concentration technology.


The patent covers Cepheid's system for using fluidic circuits in a cartridge to collect microorganism samples and automate the laborious process of nucleic acid purification and concentration. That technique is an important part of the company's GeneXpert rapid genetic testing platform, now under development.

 

The patent was awarded on Aug. 27 by the United States Patent and Trade Office.

Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.